ARTIFICIAL VISION : Pixium Vision: First Clinical Results and Innovative Developments
Pixium Vision and its partners are developing two VRS solutions for blind patients: an epi-retinal and a sub-retinal approach. This chapter describes the specificities of the epi-retinal IRIS® VRS that has obtained the European CE mark cerfication, and also discuss the associatedinnovations developed at the Vision Institute for future VRS models.
Functional Vision vs Visual Function – Working Towards Integrating Patient Perspective in Retinal Res
As the global patient-led umbrella group representing the voice of people living with Retinal Degenerative Diseases, Retina International (RI) and its members believe that the outcomes of clinical trials and therapy development would benefit from better integrating what is important to the patient.